Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$810K Sell
2,882
-48,492
-94% -$12.2M 0.08% 152
2026
Q1
$12.5M Sell
51,374
-9,853
-16% -$2.67M 1.43% 19
2025
Q4
$18.1M Buy
61,227
+43,165
+239% +$12.9M 2.11% 6
2025
Q3
$5.1M Sell
18,062
-49,442
-73% -$12.9M 0.59% 58
2025
Q2
$19.9M Sell
67,504
-5,865
-8% -$1.51M 2.53% 4
2025
Q1
$18.2M Buy
+73,369
New +$17.9M 2.65% 3
2024
Q2
Sell
-23,400
Closed -$4.07M 285
2024
Q1
$4.47M Buy
+23,400
New +$4.27M 0.58% 56

Other funds holding IBM

Genus Capital Management's IBM Position: Q2 2026 in Review

Genus Capital Management reduced its IBM (IBM) stake by 94% in Q2 2026, selling an estimated $12.2M and leaving 2,882 shares worth $810K. The position accounts for 0.08% of the portfolio, ranked #152.

Genus Capital Management first reported a position in IBM in Q1 2024 and has held it in 7 quarters since. The position peaked at $19.9M in Q2 2025. 3,625 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Genus Capital Management held 2,882 shares of IBM worth $810K as of Q2 2026.
  • Genus Capital Management sold 48,492 IBM shares in Q2 2026, an estimated $12.2M.
  • IBM made up 0.08% of Genus Capital Management's portfolio in Q2 2026, its #152 holding.
  • Genus Capital Management first reported a position in IBM in Q1 2024 and has held it in 7 quarters since.
  • Genus Capital Management's IBM position peaked at $19.9M in Q2 2025.
  • 3,625 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.